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Abstract
Eating disorders, psychotic illnesses, and substance use disorders are some of 
the more common psychiatric conditions encountered in clinical practice that are 
associated with hyponatremia. The mechanisms that lead to hyponatremia vary, 
and at times hyponatremia may be a result of a drug side effect or drug-drug inter-
action. Additionally, hyponatremia from a non-psychiatric condition may lead to 
psychiatric symptomatology. Given the potential for hyponatremia to cause signifi-
cant morbidity and potential mortality, clinicians are urged to consider screening 
for plasma sodium in patients at risk of hyponatremia, such as patients in the three 
categories of psychiatric conditions described above. Treatment of hyponatremia 
consists of various acute interventions, with consideration that treatment of the 
underlying psychiatric condition may help to diminish or eliminate the frequency 
of hyponatremic episodes in the long run.
Keywords: hyponatremia, anorexia nervosa, bulimia nervosa, psychosis,  
alcohol use disorder
1. Introduction
Sodium abnormalities can be seen in various psychiatric diseases. Common 
conditions include eating disorders, psychotic illnesses, and certain substance 
use disorders. Additionally, hyponatremia of any cause, including from drug 
side effects in patients being treated for psychiatric illnesses, can cause or worsen 
psychiatric conditions and may lead to medical comorbidities. References used in 
this chapter include articles from an online PubMed search of hyponatremia and 
psychosis spanning the past 50 years, and various Up-to-date review articles. In this 
chapter we dissect these conditions and open with a typical patient case.
1.1 Case
Lucia is a 19 year old junior majoring in Mathematics and Literature. She runs 
cross-country and has fainted multiple times while training with her teammates. On 
the recommendation of her coach she went to the student medical center for a well-
ness check. She looks thin and athletic. Vital sign checks show postural hypotension 
and orthostatic increase in pulse rate. Her BMI is calculated at 18 kg/m2. She reports 
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otherwise good health and no psychiatric concerns. She is doing well in school and 
excelling on the cross-country team.
1. What additional questions might you ask to elucidate the cause of her synco-
pal episodes? 2. What additional investigation would you find helpful?
2. Eating disorders and hyponatremia
2.1 Three main types of eating disorders
Eating disorders are characterized by a disturbance in eating or eating related 
behavior and body image associated with substantial distress and psychosocial impair-
ment and/or jeopardizing physical health [1]. Anorexia Nervosa, Bulimia Nervosa, and 
Binge Eating Disorder are the most well-known and best understood eating disorders. 
Other recognized eating disorders include avoidant/restrictive food intake disorder, 
pica, and rumination disorder. This classification scheme is mutually exclusive, such 
that during one-episode patients can carry only one diagnosis at a time. In this chapter 
we discuss the diagnostic categories that lead to hyponatremia and then focus on 
detecting and treating hyponatremia in the eating disordered patient [2].
Anorexia Nervosa is distinguished by severe restriction in nutritional intake 
leading to a BMI that is less than 18.5 kg/m2 in adults, an intense fear of becoming 
fat, gaining weight, and distortion in body shape and image. This is accompanied by 
behaviors that continue to interfere with weight gain and that stimulate weight loss. 
These behaviors include exercising, restricting food, eating low calorie foods, or 
purging by using laxatives or diuretics to lose weight.
As defined by DSM-5 [1], anorexia nervosa—restricting subtype describes 
an individual whose weight loss has been accomplished primarily by dieting and 
fasting and has not engaged in recurrent episodes of binge eating or purging in the 
last 3 months. In Anorexia nervosa—binge-eating/purging subtype, the individual 
meets criteria for anorexia nervosa and has engaged in episodes of binge-eating and 
purging over the last 3 months.
Bulimia Nervosa is characterized by recurrent episodes of binge eating and 
compensatory behavior aimed at preventing weight gain, occurring at least once a 
week for at least 3 months. Like in the binge-purge subtype of Anorexia Nervosa, 
these purging behaviors may include self-induced vomiting, misuse of diuretics, or 
laxatives, or excessive exercise. Patients may also restrict by fasting.
2.2 Electrolyte disturbances
If untreated and persistent, these two types of eating disorders result in elec-
trolyte and acid-base disturbances, affecting serum and urine sodium, potassium, 
and chloride, and serum bicarbonate and pH [3]. Common electrolyte disturbances 
include hypokalemia and hyponatremia [4]. Hyponatremia is defined by a serum 
sodium concentration of <135 mEQ/L. Patients who purge consistently lose sodium 
through fluid output; self-induce vomiting, laxatives abuse leading to diarrhea; and 
diuretic abuse, leading to excessive urination. This decrease in effective circulat-
ing vascular volume stimulates the release of antidiuretic hormone (ADH) from 
the pituitary gland leading to water reabsorption through the kidneys. The body’s 
attempt to preserve volume leads to dilution of the sodium already present in 
circulation. Hyponatremia in our eating disordered patients can be associated with 
low, normal or high serum tonicity. Hyponatremia associated with hypovolemia is 
as a result of low serum tonicity. Hyponatremia may also result from excessive water 
intake or impaired renal sodium reabsorption due to chronic starvation.
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2.3 Identifying hyponatremia
A quick screen can be utilized to investigate eating disordered patterns. 
Clinicians should use a validated eating disorder questionnaire, like the Eating 
Disorder Questionnaire Online (EDQ-O) or the SCOFF (Sick Control, One, Fat, 
Food) questionnaire to assess for the presence of an eating disorder [5]. On physical 
examination, patients who purge consistently or who restrict may appear volume 
depleted with orthostatic decreases in blood pressure, increases in pulse rate and 
decreased skin turgor. In addition to a basic metabolic panel, urine electrolyte 
screens should be completed to help elucidate the etiology of the hyponatremia. 
Patients who misuse prescribed diuretics or who use copious amounts of over the 
counter diuretics will not have low urine sodium. On the other hand, patients who 
self-induce vomiting or diarrhea will have low urinary sodium because of increased 
sodium retention through the kidneys.
2.4 Treatment
Treatment depends on the severity of hyponatremia. In the case of patients with 
eating disorders, psychiatrists and nutritionists should be consulted and involved 
in treatment and care to facilitate discontinuation of purging, and excessive water 
drinking [6]. Some hospitals have developed protocols for treating such patients, 
including observed meals and caloric counting to ensure a smooth recovery when 
food is re-introduced and for prevention of refeeding syndrome [7].
3.  Psychotic illnesses, bipolar illnesses, and obsessive-compulsive 
disorder (OCD) affecting serum sodium
3.1 Psychotic illnesses
One of the most common psychotic illnesses that affect serum sodium is schizo-
phrenia. As defined by DSM-5 [1], schizophrenia is characterized by two of more of 
the following symptoms including delusions, hallucinations, disorganized speech, 
grossly disorganized or catatonic behavior, and negative symptoms (i.e. diminished 
emotional expression) that are present for a significant portion of a 1-month period 
and continuous signs of disturbance in functioning level present for at least 6 months. 
Patients with schizophrenia can experience primary psychogenic polydipsia (PPD), 
characterized by an increase of fluid intake along with excretion of excessive amounts 
of dilute urine exceeding 40–50 mL/kg of body weight [8]. It is hypothesized that 
this occurs in patients with schizophrenia due to elevated levels of dopamine that 
stimulate the thirst center [8]. In patients with schizophrenia, polydipsia prevalence 
is estimated at 6–20%, and complications can include not just hyponatremia but rhab-
domyolysis as well [9]. Severe water intoxication has also been reported in a patient 
with delusional skin infestation leading to hyponatremia [10].
3.2 Bipolar illness
PPD has also been implicated in psychiatric patients with bipolar I disorder in a 
manic state whose increase in fluid intake can lead to hyponatremia [8]. As defined 
by DSM 5, a manic episode is a distinct period of abnormally and persistently 
elevated, expansive or irritable mood with increased activity or energy lasting 
at least 1 week that is not attributable to physiological effects of substances with 
three or more of the following symptoms present including inflated self-esteem, 
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decreased need for sleep, pressured speech, flight of ideas, distractibility, increased 
goal directed activity, and excessive involvement in activities that have a high 
potential for painful consequences such as gambling, sexual indiscretions, and 
unrestrained buying sprees. The presence of mania distinguishes bipolar I from 
bipolar II; in bipolar I a patient must meet criteria for a manic episode, which 
may have been preceded or followed by a hypomanic or major depressive episode. 
Additionally, as defined by DMS 5 [1], bipolar disorder type II is diagnosed when 
the individual meets criteria for a current or past hypomanic episode and a current 
or past major depressive episode. A hypomanic episode is defined by DSM 5 [1] as 
a distinct period of abnormally and persistently elevated, expansive or irritable 
mood with increased activity or energy lasting at least 4 days with three or more 
of the following symptoms present including inflated self-esteem, decreased need 
for sleep, pressured speech, flight of ideas, distractibility, increased goal directed 
activity, and excessive involvement in activities that have a high potential for pain-
ful consequences such as gambling, sexual indiscretions, and unrestrained buying 
sprees. Major depressive episode includes 5 or more of the following symptoms 
over a 2-week period that represent a change from previous functioning such as 
depressed mood, diminished interest in activities, significant change in weight, 
insomnia or hypersomnia, psychomotor agitation or retardation, loss of energy, 
feelings of worthlessness, decreased ability to concentrate, and recurrent thoughts 
of death.
3.3 Obessive compulsive disorder (OCD)
Obsessive-compulsive disorder as defined by DSM 5 [1] is characterized by the 
presence of obsessions, compulsions or both. Obsessions are recurrent or persistent 
intrusive thoughts that cause marked anxiety or distress that individuals try to 
ignore or suppress by performing compulsions such as repetitive behaviors or men-
tal acts including hand washing, praying, or checking behaviors. The obsessions and 
compulsions are time consuming, and distressing, and are not attributed to another 
medical condition. An interesting case of an Indian woman has been reported in 
the literature, where her behaviors of excessive water intake, intrusiveness, exces-
sive washing, cleaning, checking and perfectionism led to a diagnosis of OCD. She 
had experienced recurrent seizures with no benefit from antiepileptic medication, 
and only after further assessment it was discovered that her urge to drink excessive 
water led to consumption of 7 L of water producing hyponatremia and seizure [11]. 
This case is important because it highlights how a psychiatric condition (OCD) can 
present as a neurological emergency [11].
4.  Low serum sodium from other medical conditions contributing to 
mental health conditions
Exclusive relationships between hyponatremia, depression symptoms, and 
cognitive impairments have been reported in patients with chronic kidney disease 
who are also undergoing hemodialysis [12]. In DSM-5 [1], major depressive disorder 
is defined as a change from previous functioning that includes 5 or more of the 
following symptoms over a 2-week period of time such as depressed mood, dimin-
ished interest in activities, significant change in weight, insomnia or hypersomnia, 
psychomotor agitation or retardation, loss of energy, feelings of worthlessness, 
decreased ability to concentrate, and recurrent thoughts of death. Major neuro-
cognitive disorder is characterized by significant cognitive decline from a previous 
level of functioning in one or more cognitive domains including complex attention, 
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executive function, learning and memory, language, perceptual motor, or social 
cognition that interfere with independence in everyday activities.
Hyponatremia has also been reported in association with catatonia and delirium, 
highlighting the profound effect that hyponatremia can have on one’s mental status 
[13]. As defined by DSM 5 [1], catatonia includes a clinical picture dominated 
by three or more of the following symptoms including stupor, catalepsy (passive 
induction of posture held against gravity), waxy flexibility (slight, even positioning 
by examiner), mutism, negativism (opposition or no response), posturing, man-
nerism (odd, circumstantial caricature of normal actions), steryotypy (repetitive, 
abnormally frequent, non-global directed movements), grimacing, agitation, 
echolalia (mimicking another’s speech), and echopraxia (mimicking another’s 
movements). Mechanisms of hyponatremia leading to catatonia are not well 
elucidated. Based on case reports, it has been demonstrated multiple times that 
catatonia and delirium do occur in the context of hyponatremia. Some hypothesize 
that vasopressin regulation mediates the development of hyponatremia when one 
has catatonia with psychosis. While others argue that because only some Addison’s 
disease patients develop hyponatremia (potential implication of aldosterone as 
regulator of sodium and water balance in the distal tubules and collecting ducts 
of the kidneys) and only some of those develop catatonia that therefore there is a 
presence of susceptibility of unknown reasons with hyponatremia causing catato-
nia [13]. DSM 5 [1] defines delirium as a disturbance in attention, awareness, and 
cognition that develops over a short period of time and tends to fluctuate in severity 
over the course of the day.
5.  Drug side effects and drug-drug interactions affecting serum sodium 
in patients being treated for psychiatric conditions
5.1  Antidepressants and non-steroidal anti-inflammatory drugs (NSAIDs) 
implicated in hyponatremia
Among the classes of medications used to treat psychiatric conditions there are 
many side effects and interactions that may alter serum sodium. This is a critical 
consideration as many of the symptoms of hyponatremia, particularly generalized 
malaise and alterations in appetite can mimic symptoms of depression. A recent 
case report documented duloxetine induced hyponatremia, including symptoms 
such as “unsteady gait, dizziness, nausea, general malaise and poor appetite,” 
resolved by discontinuing duloxetine [14]. Serotonin Norepinephrine Reuptake 
Inhibitors (SNRIs), such as duloxetine, have been associated with syndrome 
of inappropriate antidiuretic hormone (SIADH) with resulting hyponatremia. 
Hyponatremia results from an inappropriately high release of antidiuretic hormone 
(ADH) from the posterior pituitary, which results in an excess retention of water 
and a low serum osmolality. In particular SNRIs act primarily to inhibit the reuptake 
of both serotonin and noradrenaline, and in experimental models it has been shown 
that both serotonin and noradrenaline can result in the increased release of ADH 
(in rat models serotonin (5-HT) activated 5-HT1A receptors cause sympathoexcita-
tion of 5HT1C and 5HT2 receptors and the release of ADH; also stimulation of the 
paraventricular and supraoptic nuclei with norepinephrine can increase release of 
ADH within the serum) [14]. Therefore, through these mechanisms it is hypoth-
esized that SNRIs cause SIADH in patients, a life-threatening side effect that must 
be monitored for by clinicians.
A case report of a patient diagnosed with schizophrenia, taking desmopressin 
and meloxicam identified that NSAIDs can significantly augment hyponatremia 
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by “increas[ing] water retention” [15]. Notably, the worsened water retention is 
particularly problematic for patients on desmopressin, and complete resolution 
of symptoms occurred after desmopressin was tapered and meloxicam stopped, 
with normalization in plasma sodium [15] (Figure 1, used with permission from 
authors).
5.2 Other medications and interactions implicated in hyponatremia
Fabrazzo et al. [16] discuss three cases involving delorazepam, olanzapine and 
fluvoxamine, respectively, in which patients with various presentations of bipolar 
disorder were hospitalized, and hyponatremia was discovered on admission. 
Workup revealed SIADH. Multiple interventions were trialed, including adminis-
tration of hypertonic saline, and decreasing doses of various medications. It was not 
until the offending medications were removed that patients demonstrated resolu-
tion of their hyponatremia. Notably, olanzapine, fluvoxamine and delorazepam 
were being administered in conjunction with other medications that may have 
contributed to the hyponatremia. In the case of the patient taking delorazepam, 
they also were prescribed oxcarbazepine, which ultimately was replaced with 
gabapentin. In the case of the patient taking olanzapine, he also was taking delo-
razepam and oxcarbazepine. Likewise, the patient on fluvoxamine was also taking 
oxcarbazepine. These medications in conjunction with one another appear to have 
an additive property on hyponatremia.
5.3 Additional considerations for antipsychotics and hyponatremia
Antipsychotic medications alone have been reported in the literature to be asso-
ciated with hyponatremia; however, recently, the long-acting risperidone injectable 
treatment has been implicated in hyponatremia as well. In this case, the patient did 
not improve simply with the removal of risperidone, due to the extended half-life, 
and ultimately required Tolvaptan administration [17]. The half-life of these medi-
cations may be an important factor in determining the management of subsequent 
hyponatremia. Along a similar vein, Fabrazzo et al. [16] detail that hyponatremia 
and other electrolyte derangements are often only detected in patients with psychi-
atric diagnoses when they are hospitalized. This is a critical consideration for clini-
cians in terms of practice, particularly whether there is an impetus for psychiatrists 
Figure 1. 
Plasma sodium levels over time.
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to consider routinely monitoring electrolytes of patients on longstanding medica-
tions with the potential for these derangements, especially in patients with bipolar 
disorder.
5.4 Practice considerations
There currently are no routine guidelines for screening of electrolyte abnormali-
ties among patients with psychiatric diagnoses and this should be further evaluated 
given the range of dangerous consequences of hyponatremia, including seizure, as 
demonstrated in at least one of the cases delineated above [15].
6. Alcohol and other substance use disorders affecting serum sodium
6.1 Alcohol and hyponatremia
Substance use is also implicated in derangements of serum sodium, particularly 
among patients who abuse alcohol and MDMA. As defined by DSM 5 [1], alcohol 
use disorder is a pattern of alcohol use within the past 12 months that has led to 
significant impairment in one’s life characterized by at least two of the following 
including alcohol taken in larger amounts, persistent desire to cut down, increased 
time obtaining alcohol, cravings, continued use despite recurrent impairment in 
social functioning, developed tolerance, and withdrawal symptoms present when 
alcohol use is ceased. As delineated in previous sections, there are profound poten-
tial consequences of hyponatremia, particularly because of sodium’s role in main-
taining nerve impulse conduction and neuromuscular excitability. Michal et al. [18] 
observed that in patients with likely alcohol use disorder, the level of derangement 
in serum sodium was associated with the worsening of physical and psychological 
quality of life; that is to say, patients with severe hyponatremia (<120 mmol/L) 
were likely to have worse quality of life than patients with low hyponatremia 
(<135 mmol/L) [18]. The specific causal pathways are not delineated; however, beer 
potomania is an observed phenomenon in which dietary insufficiency of protein, 
coupled with dietary sodium results in a sort of dilutional hyponatremia. It is pos-
sible that patients with more severe hyponatremia may be further in their disease 
course, ultimately consuming more alcohol.
6.2 MDMA (3,4-methylenedioxymethamphetamine) and hyponatremia
Stimulant use disorder in DSM-5 [1] is defined as a pattern of stimulant use 
within the past 12 months that has led to significant impairment in one’s life char-
acterized by at least two of the following including the stimulant is taken in larger 
amounts, persistent desire to cut down, increased time obtaining the stimulant, 
cravings, continued use despite recurrent impairment in social functioning, 
developed tolerance, and withdrawal symptoms present when stimulant use is 
ceased. MDMA (3,4-methylenedioxymethamphetamine), a stimulant, is thought to 
be associated with hyponatremia because of increased diaphoresis, yielding sodium 
loss, and compensatory water intoxication. It is not a common side effect of MDMA 
use; however, Armitage et al. [19] presented a case report of an 18-year-old woman 
who had a generalized tonic-clonic seizure in the setting of hyponatremia from 
MDMA intoxication. This woman’s serum sodium was 121, notably close to what 
many would argue is severe hyponatremia. Notably, MDMA related hyponatremia 
with seizure is more common among young women under 30 years of age, particu-
larly because of estrogen inhibiting the Na+-K+-ATPase. This ultimately inhibits 
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a known compensatory mechanism for cerebral edema, which may place young 
women at increased risk of neurological impacts of hyponatremia with MDMA 
use. Further, a metabolite of MDMA, 4-hydroxy-3-methoxymethamphetamine 
(HMMA), is documented to stimulate ADH release, which can worsen hyponatre-
mia. These are vital considerations given the potential sequela of seizure, and the 
urgency of its management.
7.  General treatment considerations for hyponatremia in psychiatric 
illnesses
Here, we aim to describe general considerations of hyponatremia by going over 
symptoms, treatment, and cautions.
7.1 Summary of general symptoms of hyponatremia
Symptoms of hyponatremia can be thought of as severe, moderate, and mild. 
Severe symptoms are red flag signs that include seizure and changes in cogni-
tion that can rapidly progress to coma and death. These symptoms are classically 
correlated with serum levels of less than 120. As such, these are the constellation 
of symptoms that would require hospitalization. Moderate and mild symptoms 
differ in severity but include flu like symptoms of headache, myopathy, and general 
malaise; these symptoms are observed mostly with sodium serum level ranges from 
120 to 135. Lastly, there are patients who have low serum levels but are generally 
asymptomatic, with minimal changes in gait or sensorium [20].
7.2 Treatment of hyponatremia and cautions
When treating hyponatremia, it is important to recognize that there is a high 
risk of morbidity and mortality in conditions where hyponatremia develops within 
48 h, post-op hyponatremia in female and pediatric populations, patients with 
history of cerebral pathology, as well as those presenting with psychosis (because 
they could have ingested large amounts of water). Regardless of symptom severity, 
it is important to note that increasing serum sodium level by 4–6 mEq/L in 24 h can 
reverse symptoms, and the rate should never exceed 8 mEq/L in a day, as rates faster 
than this can increase risk of demyelination [20]. Asymptomatic hyponatremia, if 
mild, may be left untreated.
Interventions commonly used in the context of treating hyponatremia include 
fluid restriction, increasing dietary salt, potassium replacements, hypertonic saline, 
and vasopressin antagonists, with selection based on the etiology and severity 
of the hyponatremia. Fluid restriction is most helpful in the context of volume 
overload (such as heart failure or cirrhosis), SIADH, renal failure, or if the patient 
has polydipsia. The amount of fluid restriction is determined often with nutritional 
consultation; this is the gold standard approach in treatment of SIADH. Patients 
may initially start with fluid restriction to 500 mL/d. Pharmacotherapy is typically 
considered if serum sodium has not improved with fluid restriction over 48 h [21].
Pharmacotherapy includes a broad range of options, including dietary salts and 
oral salt tablets, potassium replacements and vasopressin antagonists. Dietary salts 
and oral salt tablets are generally utilized for patients with mild to asymptomatic 
symptoms with SIADH. Potassium replacements are helpful when patients are 
developing conditions that are causing hypokalemic states as well, such as inappro-
priate diuretic uses and excessive vomiting. These may be associated with feeding 
and eating disorders, and additional considerations for the treatment of those 
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disorders may include 1:1 supervision for prevention of continued vomiting, and 
consultation with nutrition to minimize risk of refeeding during early hospitaliza-
tion. Vasopressin antagonists will cause water loss, making it non-ideal for patients 
with volume deficits.
The clinician must always be wary of any contributing factors causing the 
hyponatremia; for example, if the patient has adrenal insufficiency, glucocorti-
coid replacement will be crucial. In this case, endocrinology consultation may be 
appropriate. Likewise, if the patient has drug induced SIADH, it is important to 
re-visit the necessity of the drugs and to find replacements if able; common culprits 
include SSRIs like fluoxetine and sertraline [20]. The clinician and the patient 
should have a conversation about the risks, benefits, and alternatives to continuing 
treatment with an offending agent and informed consent should be documented 
whether the medication is maintained or switched. In patients with psychogenic 
polydipsia associated with antipsychotic medication use, treatment of the underly-
ing psychotic disorder coupled with behavioral intervention to limit water intake 
may decrease the frequency of hyponatremic episodes and lessen morbidity. In 
patients with substance use disorders, particularly alcohol use disorder, psychoedu-
cation and motivational interviewing surrounding their substance use disorder and 
risks of hyponatremia, including increased risk of seizure, may be a helpful part 
of decreasing use of substance. These patients should also be offered medication 
assisted treatment for their substance use disorder when appropriate and desired by 
the patient.
In sum, hyponatremia in psychiatric conditions is best treated in a comprehen-
sive, multi modal approach. With many etiologies, including SIADH, endocrine 
pathologies, feeding and eating disorders, and delirium, consultation with different 
medical specialties and nutritional teams may augment and improve the treatment 
of hyponatremia. Regardless of etiology, psychoeducation and involvement of the 
patient in shared decision making is essential in understanding the future course of 
treatment.
8. Conclusion
Hyponatremia is a complex electrolyte disturbance which can both manifest with 
psychiatric symptoms, and can be associated with psychiatric disease itself. Eating 
disorders, psychotic illnesses, and substance use disorders are some of the more com-
mon psychiatric conditions encountered in practice that are associated with hypona-
tremia. The mechanisms that lead to hyponatremia vary, and at times hyponatremia 
may be a result of a drug side effect or drug-drug interaction. Given the potential for 
hyponatremia to cause significant morbidity and potential mortality, clinicians are 
urged to consider screening for plasma sodium in patients at risk of hyponatremia, 
such as patients in the three categories of psychiatric conditions described above. 
Treatment considerations include: (1) understanding the underlying etiology of the 
hyponatremia, (2) asymptomatic mild hyponatremia may not need treatment, (3) 
fluid restriction is the initial treatment of choice for SIADH, (4) hypertonic saline is 
used to correct moderate-severe hyponatremia, but should be done only under the 
guidance of medical teams to avoid demyelination syndromes, (5) there may be other 
considerations, such as 1:1 supervision for feeding-eating disorders, (6) specialty con-
sultation may be appropriate in determining course of treatment, such as nutrition for 
advancement of diet, or endocrinology for concomitant adrenal pathology. Treatment 
of hyponatremia consists of various acute interventions, with consideration that treat-
ment of the underlying psychiatric condition may help to diminish or eliminate the 
frequency of hyponatremic episodes in the long run.
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9. Case consideration
1. The patient should have a comprehensive assessment, which includes a medical 
interview, physical exam, and tests as needed. This assessment should include 
questions about diet, alcohol and drug use, exercise regimen, and past and 
current medical and psychiatric histories.
2. Additional investigations can include checking blood electrolytes and an 
EKG. In patients with eating disorders, one can see derangements in sodium 
and potassium (usually hyponatremia or hypokalemia or both). EKG may 
show QT prolongation.
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